RAYMOND MILLER: Open Payments
NPI 1518401397 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,573 in 78 payments from 22 companies in 2025. Trend: 2023 $1,344 · 2024 $1,216 · 2025 $1,573
Food & beverage: $1,392Education: $182
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 16 | $257 |
| ABBVIE INC. | 11 | $219 |
| Astellas Pharma US Inc | 3 | $184 |
| PFIZER INC. | 7 | $136 |
| Endo USA, Inc. | 6 | $111 |
| ACCORD HEALTHCARE, INC. | 6 | $110 |
| Ferring Pharmaceuticals Inc. | 4 | $68 |
| Janssen Biotech, Inc. | 3 | $65 |
| Procept Biorobotics Corporation | 3 | $64 |
| 180 Medical, Inc. | 3 | $56 |
Products named: BOTOX, GEMTESA, XTANDI, ORGOVYX, Camcevi, AVEED, ADSTILADRIN, ERLEADA.
Industry payments across UT — which companies pay providers there.
